Agents for potentiating the effects of antitumor agents and comb

Details Agents for potentiating the effects of antitumor agents and comb Agents for potentiating the effects of antitumor agents and comb

1990-06-18

1994-04-05

Waddell, Frederick E.

Drug, bio-affecting and body treating compositions

Identification or warning feature

Taste or smell or chemical irritation to the eye, nose, or...

514217, 514265, 514268, 514350, 514352, 514427, 514450, A61K 4900, A61K 3140, A61K 31335, A01N 4346

Patent

active

053002822

ABSTRACT:
Potentiating agents which enhance the efficacy of antineoplastic agents are disclosed. The potentiating agents disclosed are dibenz[b,e]oxepins such as doxepin.

REFERENCES:
patent: 3420851 (1969-01-01), Bloom et al.
patent: 3497596 (1970-02-01), Ursillo
patent: 3993757 (1976-11-01), Freedman
patent: 3996222 (1976-12-01), Kajfez et al.
patent: 4562258 (1985-12-01), Findlay et al.
patent: 4628047 (1986-12-01), Sakurai et al.
patent: 4650807 (1987-03-01), Findlay et al.
patent: 4657918 (1987-04-01), Findlay et al.
patent: 4690933 (1987-09-01), Coker et al.
patent: 4990538 (1991-02-01), Harris et al.
Letter from Avner Ramu, M.D., Dept. of Radiation and Clinical Oncology, Apr. 20, 1987.
The Merck Index, An Encyclopedia of Chemicals, Drugs, and Biologicals (11th Ed.) (Merck & Co., Inc. N.J.) 1989, p. 3192.

Affiliated with

Also associated with

Rating

Agents for potentiating the effects of antitumor agents and comb does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Agents for potentiating the effects of antitumor agents and comb, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Agents for potentiating the effects of antitumor agents and comb will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-509380